In the vein of yesterday’s post, here is more from Dr. Jefferson regarding the H1N1 flu. There is also a link to a similar cultural phenomenon regarding osteoporosis.
October 20, 2009
October 19, 2009
This article, from the online edition of the Atlantic, is a review of the effectiveness and use of influenza vaccines, and of the controversy around these issues.
October 12, 2009
A colleague, Dr. Louise Sanchione, sent me a link on homeoprophylaxis, the use of homeopathic medicines to prevent epidemic disease.
I think that this is an interesting presentation. The comparisons to conventional treatment are a bit problematic, however, since conventional care has improved greatly since the majority of these epidemics happened. The epidemic of meningitis in Brazil is the best documented of all these examples.
Another colleague, Molly Punzo, MD, in Baltimore, has seen a few Novel H1N1 cases recently and has had good results with the remedy China officinalis (commonly known as China). I haven’t seen any cases in my practice as of the present time, although there are always a few people with fevers, so I may have. I’ve certainly seen nothing serious or long-lasting.
I wrote yesterday regarding Squalene, but I see in this morning’s NY Times that the vaccine for the Novel H1N1 vaccine sold used in this country does NOT have squalene, or any other adjuvant, as a component.
October 11, 2009
I’ve called it swine flu but this is probably unfair. All human influenza viruses are mixtures of human, bird, and pig virus. The current terminology for the virus which is causing the current pandemic is the “Novel H1N1” virus.
The incidence of this virus is still increasing, at least as of the data of one week ago. At this point the mortality rate appears to be about the same as the usual seasonal influenza, or perhaps a bit higher.
Supplies of the Novel H1N1 vaccine have just started to be released, but are still in short supply.
I have seen no reports of safety issues regarding the vaccine. The single dose vials contain a trace of thimerosal (a mercury based preservative) while the multi-dose vials have a larger amount.
A recent New York Times article summarized the issues around the Novel H1N1 virus and vaccination, and stated that there were no adjuvants (substances in addition to virus or viral components that act to enhance the body’s immune response). I have understood, however, that the vaccine does contain squalene, a substance commercially derived from shark liver oil. Various commentators in the “alternative” medical world have reacted strongly against the inclusion of squalene, considering it to be toxic. The World Health Organization has sought to allay these fears. Their response may be found here.
The same NY Times article summarized the risk for Guillain-Barre syndrome (paralysis) from the (real) Swine Flu vaccine of 1976. The risk has been estimated to be from 1 in 100,000 to as low as 1 in 1,000,000. They contrast this with the risk of death from the flu of one in 8300 Americans. I am uncertain as to the exact meaning of this last figure. Does it refer to all Americans regardless of whether they have flu or not (eg another figure is 36,000 Americans die each year of the flu).
As always, the decision to vaccinate or not to vaccinate should depend upon one’s age, medical condition, circumstances, etc. But everyone can practice good hygiene, take adequate amounts of Vitamin D (see my article on influenza), and use common sense in terms of coming into contact with people who are sick during an epidemic.